- Mar 2
- 2 min
USFDA Guidance: Reporting Amount of Listed Drugs and Biological Product and Key Information and Facilitating Understanding in Informed Consent Guidance
- Mar 2
- 2 min
EMA: QRD updation and Product-Information Templates Updation
- Mar 2
- 2 min
UK MHRA Guidance: Navigating on Applying for a Licence to Market a Medicine
- Feb 22
- 2 min
South Africe SAPHRA: Guidelines For Medicine Recalls – Withdrawals And Rapid Alerts
- Feb 22
- 1 min
TGA MD Guidance: Medical Device Labelling Obligations
- Feb 17
- 1 min
USFDA Guidance: Q&A-Charging for Investigational Drugs Under an IND - What You Need to Know
- Feb 17
- 2 min
EMA Guidance: Electronic Submission of Information for Investigational Medicinal Products in XEVMPD
- Feb 13
- 2 min
USFDA Guidance: Use of Data Monitoring Committees in Clinical Trials
- Feb 13
- 2 min
USFDA CMC Guidance: Advanced Manufacturing Technologies Designation Program
- Feb 7
- 2 min
Swissmedic Guidance: Navigating Variations, Product Information, and Electronic ICSRs through PV Gateway
- Feb 7
- 2 min
USFDA Guidance: "Understanding the USFDA Notification Process for Discontinuance or Interruption in Manufacturing of Pharmaceutical Products"